Alnylam Pharmaceuticals (NASDAQ:ALNY) has outperformed the market over the past 15 years by 8.34% on an annualized basis producing an average annual return of 20.61%. Currently, Alnylam Pharmaceuticals has a market capitalization of $36.14 billion.
Buying $1000 In ALNY: If ...